Rudy Li
Stock Analyst at Chardan Capital
(4.85)
# 76
Out of 5,005 analysts
28
Total ratings
75%
Success rate
41.49%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rudy Li
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
IMUX Immunic | Initiates: Buy | $3 | $0.98 | +206.65% | 1 | Sep 29, 2025 | |
ANRO Alto Neuroscience | Initiates: Buy | $15 | $6.89 | +117.71% | 1 | Sep 29, 2025 | |
RVPH Reviva Pharmaceuticals Holdings | Initiates: Buy | $2 | $0.55 | +266.97% | 1 | Sep 29, 2025 | |
PRTA Prothena Corporation | Maintains: Buy | $18 | $9.92 | +81.45% | 7 | Aug 28, 2025 | |
STOK Stoke Therapeutics | Maintains: Buy | $24 | $25.56 | -6.10% | 4 | Aug 13, 2025 | |
XENE Xenon Pharmaceuticals | Maintains: Buy | $55 | $39.61 | +38.85% | 3 | Aug 12, 2025 | |
CNTA Centessa Pharmaceuticals | Maintains: Buy | $30 | $23.23 | +29.14% | 3 | Aug 12, 2025 | |
MNMD Mind Medicine (MindMed) | Maintains: Buy | $20 | $12.56 | +59.24% | 4 | Aug 1, 2025 | |
PRAX Praxis Precision Medicines | Maintains: Buy | $80 | $54.38 | +47.11% | 2 | Jul 29, 2025 | |
DRUG Bright Minds Biosciences | Maintains: Buy | $80 | $53.26 | +50.21% | 2 | May 21, 2025 |
Immunic
Sep 29, 2025
Initiates: Buy
Price Target: $3
Current: $0.98
Upside: +206.65%
Alto Neuroscience
Sep 29, 2025
Initiates: Buy
Price Target: $15
Current: $6.89
Upside: +117.71%
Reviva Pharmaceuticals Holdings
Sep 29, 2025
Initiates: Buy
Price Target: $2
Current: $0.55
Upside: +266.97%
Prothena Corporation
Aug 28, 2025
Maintains: Buy
Price Target: $18
Current: $9.92
Upside: +81.45%
Stoke Therapeutics
Aug 13, 2025
Maintains: Buy
Price Target: $24
Current: $25.56
Upside: -6.10%
Xenon Pharmaceuticals
Aug 12, 2025
Maintains: Buy
Price Target: $55
Current: $39.61
Upside: +38.85%
Centessa Pharmaceuticals
Aug 12, 2025
Maintains: Buy
Price Target: $30
Current: $23.23
Upside: +29.14%
Mind Medicine (MindMed)
Aug 1, 2025
Maintains: Buy
Price Target: $20
Current: $12.56
Upside: +59.24%
Praxis Precision Medicines
Jul 29, 2025
Maintains: Buy
Price Target: $80
Current: $54.38
Upside: +47.11%
Bright Minds Biosciences
May 21, 2025
Maintains: Buy
Price Target: $80
Current: $53.26
Upside: +50.21%